You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Generic Companies with Tentative Approvals for: Impax Labs


✉ Email this page to a colleague

« Back to Dashboard


Impax Labs Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Impax Labs apixaban 209810 5MG TABLET; ORAL
Impax Labs venlafaxine hydrochloride 078057 75MG CAPSULE, EXTENDED RELEASE; ORAL
Impax Labs venlafaxine hydrochloride 078057 37.5MG CAPSULE, EXTENDED RELEASE; ORAL
Impax Labs apixaban 209810 2.5MG TABLET; ORAL
Impax Labs Inc duloxetine hydrochloride 090669 EQ 30MG BASE CAPSULE, DELAYED RELEASE; ORAL
>Applicant >Generic Name >NDA >Strength >Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.